MONDAY, April 16, 2018 -- Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients' risk of their cancer returning, a new study found.
Last May, Keytruda (pembrolizumab) became the first ever drug approved by the U.S. Food and Drug Administration to fight cancers based on specific tumor genetics, rather than where in the body the tumor occurs.
WEDNESDAY, April 4, 2018 -- Even though it's widely known that tanning bed use greatly increases the odds for skin cancer, 70 percent of Americans who've used the devices have never had a doctor check them for the disease.
That's the finding from a new study of data on more than 30,000 U.S. adults.
TUESDAY, March 20, 2018 -- Doctors should start early with skin cancer prevention advice when their patients are light-skinned, suggests new guidelines that bump that starting point back to the age of 6 months.
This recommendation, from the U.S. Preventive Services Task Force, updates a 2012 recommendation that advised doctors not begin this education until children reached the age of 10.